# The Clinical and Prognostic Features of PRES

> **NCT05143710** · — · COMPLETED · sponsor: **Dunjin Chen** · enrollment: 354 (actual)

## Conditions studied

- Posterior Reversible Encephalopathy Syndrome
- Pregnancy Outcomes
- Preeclampsia
- Eclampsia

## Interventions

- **DIAGNOSTIC_TEST:** PRES in PE or E

## Key facts

- **NCT ID:** NCT05143710
- **Lead sponsor:** Dunjin Chen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-01
- **Primary completion:** 2022-01-31
- **Final completion:** 2022-01-31
- **Target enrollment:** 354 (ACTUAL)
- **Last updated:** 2022-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05143710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05143710, "The Clinical and Prognostic Features of PRES". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05143710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*